Preliminary data about female malignant breast tumours in Cambodia

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 2, 2011, Pages 383-385

  Serey, Vannak Hou ^a   Kim, Eng Sok ^a   Monchy, Didier ^b  

^a INSTITUT PASTEUR DU CAMBODGE   (Cambodia)

^b INSTITUT PASTEUR DE BANGUI   (Central African Republic)

Author keywords

Breast; Cambodia; Carcinoma; Malignant tumours; Phyllodes tumours

Indexed keywords

EID: 79958810698     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Ahmed HG, Ali AS, Almobarak AO (2010). Frequency of breast cancer among Sudanese patients with breast palpable lumps. Indian J Cancer, 47, 23-6.
2. Albrektsen G, Heuch I, Thoresen SO (2010). Histological type and grade of breast cancer tumors by parity, age at birth, and time since birth: a register-based study in Norway. BMC Cancer, 10, 226.
3. Anderson WF, Pfeiffer RM, Dores GM et al (2006). Comparison of age distribution patterns for different histopathologic types of breast carcinoma. Cancer Epidemiol Biomarkers Prev, 15, 1899-905.
4. Bernstein L, Deapen D, Ross RK (1993). The descriptive epidemiology of malignant cystosarcoma phyllodes tumors of the breast. Cancer, 71, 3020-4.
5. Elston CW, Ellis IO (1991). Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term followup. Histopathology, 19, 403-10.
6. Ferlay J, Shin HR, Bray F, et al (2010). GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer. Available from: http://globocan.iarc.fr.
7. Fong M, Henson DE, Devesa SS, et al (2006). Inter- and intraethnic differences for female breast carcinoma incidence in the continental United States and in the state of Hawaii. Breast Cancer Res Treat, 97, 57-65.
8. Li CI, Uribe DJ, Daling JR (2005). Clinical characteristics of different histologic types of breast cancer. Br J Cancer, 93, 1046-52.
9. Mathers CD, Loncar D (2006). Projections of Global Mortality and Burden of Disease from 2002 to 2030, PLoS Med http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.0030442.
10. Rakha EA, Patel A, Powe DG, et al (2010). Clinical and biological significance of E-cadherin protein expression in invasive lobular carcinoma of the breast. Am J Surg Pathol, 34, 1472-9.
11. Rosenfeld JC, De Laurentis DA, Lerner H (1981). Cystosarcoma phyllodes. Diagnosis and management. Cancer Clin Trials, 4, 187-93.
12. Sheikh MK, Khan FA, Imran Abdul Khalid IK, et al (2009). Age specific histologic types of carcinoma breast in Malaysians, J Coll Physicians Surg Pak, 19, 201-2.
13. Singletary SE, Greene FL (2003). Revision of breast cancer staging: the 6th edition of the TNM Classification. Breast Task Force. Semin Surg Oncol, 21, 53-9.
14. Slamon DJ, Clark GM, Wong SG, et al (1987). Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science, 235, 177-182.
15. Trabelsi A, Rammeh S, Stita W, et al (2008). Detection of Epstein-Barr virus in breast cancers with lymphoid stroma. Ann Biol Clin, 66, 59-62 (in French).
16. Yi JK, Prows SL (1996). Breast cancer screening practices among Cambodian women in Houston, Texas. J Cancer Educ, 11, 221-5.